UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062109
Receipt number R000071067
Scientific Title An initiative for frailty prevention by improving intestinal environment in community-dwelling elderly
Date of disclosure of the study information 2026/07/01
Last modified on 2026/07/01 15:59:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An initiative for frailty prevention by improving intestinal environment in community-dwelling elderly

Acronym

An initiative for frailty prevention by improving intestinal environment in community-dwelling elderly

Scientific Title

An initiative for frailty prevention by improving intestinal environment in community-dwelling elderly

Scientific Title:Acronym

An initiative for frailty prevention by improving intestinal environment in community-dwelling elderly

Region

Japan


Condition

Condition

Healthy elderly

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of 8-week intake of a prebiotic sweetener (containing inulin, kestose, and agaro-oligosaccharide) on dietary habits, gut microbiota (diversity, abundance of beneficial bacteria), and frailty-related factors (physical function, cognitive function, and nutritional status) in healthy elderly individuals residing in N City.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Gut microbiota

Key secondary outcomes

Health and nutritional status (Kihon Checklist, MNA-SF, CNAQ), exercise habits (IPAQ), body composition (body weight, body fat percentage, muscle mass), physical function (grip strength, gait speed, masticatory performance), cognitive function (reaction time, attention, visual learning, memory), and nutrient intake (BDHQ).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily intake of prebiotic sweetener (syrup containing inulin, kestose, and agaro-oligosaccharide) using a dedicated spoon (approx. 17g/day: containing 3.4g kestose, 8.5g inulin, and 17mg agaro-oligosaccharide) at breakfast for 8 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy residents of N City aged 65 or older will be recruited through the city's public relations newsletter. Eligible participants include both men and women who have no physician-diagnosed gastrointestinal diseases and have provided written informed consent.

Key exclusion criteria

-

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Kotoyo
Middle name
Last name Fujiki

Organization

Nagoya University of Arts and Sciences

Division name

School of Nutritional Sciences, Department of Nutritional Sciences

Zip code

470-0196

Address

57 Takenoyama, Iwasaki-cho, Nisshin-shi, Aichi, Japan

TEL

0561-75-2573

Email

kfujiki@nuas.ac.jp


Public contact

Name of contact person

1st name Kotoyo
Middle name
Last name Fujiki

Organization

Nagoya University of Arts and Sciences

Division name

School of Nutritional Sciences, Department of Nutritional Sciences

Zip code

470-0196

Address

57 Takenoyama, Iwasaki-cho, Nisshin-shi, Aichi, Japan

TEL

0561-75-2573

Homepage URL


Email

kfujiki@nuas.ac.jp


Sponsor or person

Institute

Nagoya University of Arts and Sciences

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Research Ethics Committee of Nagoya University of Arts and Sciences.

Address

57 Takenoyama Iwasaki-cho Nisshin-city Aichi pref.

Tel

0561-75-7111

Email

kitagawa@nuas.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

21

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 08 Month 19 Day

Date of IRB

2024 Year 09 Month 23 Day

Anticipated trial start date

2024 Year 10 Month 22 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 01 Day

Last modified on

2026 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000071067